** Shares of calibration service provider Transcat TRNS.O down as much as 8.5% to $79.19
** Brokerage Oppenheimer downgrades stock to "perform" from "outperform", removes PT
** Company posted Q3 results below expectations and lowered FY25 organic service growth forecast after market close on Monday, sending shares down as much as 24.2% on Tuesday
** Brokerage cites weaker forecast, reduced growth and margin improvement expectations, and impaired management credibility behind downgrade
** Says investors lost confidence in the company's growth stability, even as the company expects to return to historical growth rates in FY26, as reduced forecast implies organic service revenue decline in present quarter
** Three of five brokerages rate the stock "buy", two "hold"; with a median PT of $106, according to data compiled by LSEG
** TRNS fell ~3% in 2024
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.